The rise and rise of drug delivery

被引:215
作者
Rosen, H
Abribat, T
机构
[1] Gilead Sci Inc, Foster City, CA 94404 USA
[2] OPi Pharmaceut, Jardins Ecole, F-69760 Lyon, France
关键词
D O I
10.1038/nrd1721
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Drug delivery has typically focused on optimizing marketed compounds, improving their effectiveness or tolerability, and simplifying their administration. This role now includes the first biopharmaceuticals as well as more conventional drugs. As drug-delivery technologies come into play earlier in the development cycle, however, they can also enhance the screening and evaluation of new compounds and 'rescue' failed compounds, such as those with low solubility. In this article, we look back at how the burgeoning field of drug delivery came into being and describe approaches for future discovery and development.
引用
收藏
页码:381 / 385
页数:5
相关论文
共 41 条
[1]   The next generation of liposome delivery systems: Recent experience with tumor-targeted, sterically-stabilized immunoliposomes and active-loading gradients [J].
Abra, RM ;
Bankert, RB ;
Chen, F ;
Egilmez, NK ;
Huang, K ;
Saville, R ;
Slater, JL ;
Sugano, M ;
Yokota, SJ .
JOURNAL OF LIPOSOME RESEARCH, 2002, 12 (1-2) :1-3
[2]   Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence [J].
Anderson, RU ;
Mobley, D ;
Blank, B ;
Saltzstein, D ;
Susset, J ;
Brown, JS .
JOURNAL OF UROLOGY, 1999, 161 (06) :1809-1812
[3]   Lanreotide 60 mg, a new long-acting formulation: Effectiveness in the chronic treatment of acromegaly [J].
Attanasio, R ;
Baldelli, R ;
Pivonello, R ;
Grottoli, S ;
Bocca, L ;
Gasco, V ;
Giusti, M ;
Tamburrano, G ;
Colao, A ;
Cozzi, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) :5258-5265
[4]   Efficacy of Sandostatin® LAR® (long-acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and/or radiotherapy [J].
Ayuk, J ;
Stewart, SE ;
Stewart, PM ;
Sheppard, MC .
CLINICAL ENDOCRINOLOGY, 2004, 60 (03) :375-381
[5]   Novel mechanisms and devices to enable successful transdermal drug delivery [J].
Barry, BW .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (02) :101-114
[6]  
BLEDERMAN J, 2003, PAEDIAT DRUGS, V5, P833
[7]   Effects of nasal calcitonin on bone mineral density following parathyroidectomy in patients with primary hyperparathyroidism [J].
Casez, JP ;
Tschopp, P ;
Tschopp, AS ;
Lippuner, K ;
Zingg, E ;
Jaeger, P .
HORMONE RESEARCH, 2003, 59 (06) :263-269
[8]   Design and development of multiparticulate system for targeted drug delivery to colon [J].
Chourasia, MK ;
Jain, SK .
DRUG DELIVERY, 2004, 11 (03) :201-207
[9]   DRUG RELEASE MODULATION BY PHYSICAL RESTRICTIONS OF MATRIX SWELLING [J].
COLOMBO, P ;
CONTE, U ;
GAZZANIGA, A ;
MAGGI, L ;
SANGALLI, ME ;
PEPPAS, NA ;
LAMANNA, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 63 (01) :43-48
[10]   MULTILAYERED HYDROPHILIC MATRICES AS CONSTANT RELEASE DEVICES (GEOMATRIX(TM) SYSTEMS) [J].
CONTE, U ;
MAGGI, L ;
COLOMBO, P ;
LAMANNA, A .
JOURNAL OF CONTROLLED RELEASE, 1993, 26 (01) :39-47